CB Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2463 Impala Dr, Carlsbad, California, 92...Phone Number
(833) 322-8437Website
www.cbthera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CB Therapeutics
CB Therapeutics, Inc., located in San Diego, California, is a leading biotechnology company focusing on the innovative production of tryptamines, cannabinoids, and their analogs. CB Therapeutics' expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields, and with higher purity, consistency, and efficiency than competitive platforms. The CB Therapeutics platform can not only make the active compounds and phytochemicals that occur naturally, but by using enzymatic processes CB Therapeutics has been able to create bio-identical compounds as well as their analogs. These analog compounds may prove to be more effective, targeted, and safer for therapeutic purposes.Explore more
CB Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CB Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CB Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CB Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CB Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CB Therapeutics has new funding data
Check out if CB Therapeutics is spiking on competitors!
Product Launch: Get notified when CB Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on CB Therapeutics recently announced quarterly report
Check if CB Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CB Therapeutics
Find 2 more new buyers
Compare Similar Companies to CB Therapeutics
Compare insights from companies similar to CB Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CB Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CB Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CB Therapeutics.
CB Therapeutics financials insights
Gather financial insights about CB Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$7.5M
2020
Debt
$150K
CB Therapeutics Tech Stack
A closer look at the technologies used by CB Therapeutics
Most Recent Scoops
Funding
Funding
CB Therapeutics has received an SBA PPP loan for $150,000 from Customers Bank, supporting the retention of 18 jobs.
Award
Award
Funding
Funding
Top Business Services Companies
Frequently Asked Questions Regarding CB Therapeutics
Sign Up For FreeTo access detailed company insights
CB Therapeutics, Inc., located in San Diego, California, is a leading biotechnology company focusing on the innovative production of tryptamines, cannabinoids, and their analogs. CB Therapeutics' expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, a... Read More
